CCB
TAK icon

Cutter & Co Brokerage’s Takeda Pharmaceutical TAK Stock Holding History

Cutter & Co Brokerage’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-36,279
Closed -$480K – 236
2024
Q4 		$480K Sell
36,279
-4,906
-12% -$67.4K 0.12% 101
2024
Q3 		$586K Sell
41,185
-789
-2% -$11.2K 0.13% 91
2024
Q2 		$543K Buy
41,974
+1,347
+3% +$17.8K 0.13% 93
2024
Q1 		$564K Buy
40,627
+2,813
+7% +$40.9K 0.14% 89
2023
Q4 		$540K Buy
37,814
+638
+2% +$9.05K 0.15% 89
2023
Q3 		$575K Buy
37,176
+1,535
+4% +$23.8K 0.17% 83
2023
Q2 		$560K Buy
35,641
+1,004
+3% +$16.4K 0.17% 88
2023
Q1 		$571K Buy
34,637
+282
+0.8% +$4.49K 0.18% 89
2022
Q4 		$536K Sell
34,355
-2,920
-8% -$40.8K 0.18% 90
2022
Q3 		$483K Sell
37,275
-4,581
-11% -$63.7K 0.18% 102
2022
Q2 		$588K Buy
41,856
+4,890
+13% +$69.8K 0.2% 97
2022
Q1 		$529K Buy
36,966
+3,115
+9% +$45.7K 0.16% 111
2021
Q4 		$461K Buy
33,851
+5,551
+20% +$77.9K 0.13% 135
2021
Q3 		$464K Buy
+28,300
New +$475K 0.11% 167

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Cutter & Co Brokerage's TAK Position: Q1 2025 in Review

Cutter & Co Brokerage sold out of Takeda Pharmaceutical (TAK) in Q1 2025, closing a stake of 36,279 shares — an estimated $480K sold.

Cutter & Co Brokerage first reported a position in TAK in Q3 2021 and held it in 14 quarters. The position peaked at $588K in Q2 2022. 308 funds tracked by Wall St. Rank hold TAK as of Q1 2025.

  • Cutter & Co Brokerage reported no remaining Takeda Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Cutter & Co Brokerage sold 36,279 Takeda Pharmaceutical shares in Q1 2025, an estimated $480K.
  • Cutter & Co Brokerage first reported a position in Takeda Pharmaceutical in Q3 2021 and held it in 14 quarters.
  • Cutter & Co Brokerage's Takeda Pharmaceutical position peaked at $588K in Q2 2022.
  • 308 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2025.

Based on Cutter & Co Brokerage's 13F filing for Q1 2025, filed 1 May 2025.